🇺🇸 FDA
Pipeline program

Optimal hypoglycemic treatment

KY20170904-03

Approved other active

Quick answer

Optimal hypoglycemic treatment for Type2 Diabetes is a Approved program (other) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
First Tracks Biotherapeutics
Indication
Type2 Diabetes
Phase
Approved
Modality
other
Status
active

Clinical trials